If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMULIN® (insulin human): Use With COVID-19 Vaccinations
Use of COVID-19 Vaccines in Patients Receiving Insulin Human
The safety and efficacy of insulin human used in patients who have received a COVID-19 vaccine have not been studied by Eli Lilly and Company. Please talk to your health care provider about whether you should get a COVID-19 vaccine.
For additional questions regarding your treatment with insulin human and a COVID-19 vaccine, contact your health care provider. For current information and updates on a potential COVID-19 vaccine, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.
Date of Last Review: January 25, 2021